These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10854076)

  • 1. Endothelial dysfunction in arterial hypertension.
    Contreras F; Rivera M; Vásquez J; De la Parte MA; Velasco M
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S20-5. PubMed ID: 10854076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New aspects of the pathophysiology and pathogenesis of arterial hypertension--a review of the literature].
    Franz C; Linss G; Franz N
    Z Gesamte Inn Med; 1990 Dec; 45(24):723-8. PubMed ID: 2151671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension alters the endothelial-dependent biphasic response of bradykinin in isolated Microminipig basilar artery.
    Zahorul Islam M; Kawaguchi H; Miura N; Miyoshi N; Yamazaki-Himeno E; Shiraishi M; Miyamoto A; Tanimoto A
    Microvasc Res; 2017 Nov; 114():52-57. PubMed ID: 28587989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function.
    Izzo JL
    Heart Dis; 2000; 2(5):380-3. PubMed ID: 11728286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined oral contraceptive-induced hypertension is accompanied by endothelial dysfunction and upregulated intrarenal angiotensin II type 1 receptor gene expression.
    Olatunji LA; Seok YM; Igunnu A; Kang SH; Kim IK
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1147-1157. PubMed ID: 27447455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events.
    Enseleit F; Hürlimann D; Lüscher TF
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S21-30. PubMed ID: 11392475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction in endothelium-dependent vasodilatation.
    Busse R; Fleming I; Hecker M
    Eur Heart J; 1993 Nov; 14 Suppl I():2-9. PubMed ID: 8293777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular wall function as a risk marker for cardiovascular disease.
    Cohn JN
    J Hypertens Suppl; 1999 Dec; 17(5):S41-4. PubMed ID: 10706325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Working under pressure: the vascular endothelium in arterial hypertension.
    Spieker LE; Noll G; Ruschitzka FT; Maier W; Lüscher TF
    J Hum Hypertens; 2000; 14(10-11):617-30. PubMed ID: 11095155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role and clinical importance of nitric oxide-endothelin system in hypertension].
    Katona E; Juhász M; Varga Z; Paragh G; Fülesdi B; Páll D
    Orv Hetil; 2006 Sep; 147(38):1819-24. PubMed ID: 17066598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular renin-angiotensin-system, endothelial function and atherosclerosis?
    Holtz J; Goetz RM
    Basic Res Cardiol; 1994; 89 Suppl 1():71-86. PubMed ID: 7945178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On arterial physiology, pathophysiology of vascular compliance, and cardiovascular disease.
    Glasser SP
    Heart Dis; 2000; 2(5):375-9. PubMed ID: 11728285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction and hypertension in aging.
    Higashi Y; Kihara Y; Noma K
    Hypertens Res; 2012 Nov; 35(11):1039-47. PubMed ID: 22972557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the arterial wall, but what is the target?
    Shantsila E; Lim HS
    J Hum Hypertens; 2009 Jan; 23(1):1-3. PubMed ID: 18509342
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endothelial dysfunction on initial stages of arterial hypertension among men of young age and it's connection with vascular risk factors].
    Shmorgun TS; Bovtiushko PV; Shakhnovich PG; Nikitin AE; Filippov AE; Zubenko AI
    Voen Med Zh; 2010 Apr; 331(4):20-5. PubMed ID: 20564946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease.
    Cohen RA
    Prog Cardiovasc Dis; 1995; 38(2):105-28. PubMed ID: 7568902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: General mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of Hypertension.
    Rossi GP; Seccia TM; Barton M; Danser AHJ; de Leeuw PW; Dhaun N; Rizzoni D; Rossignol P; Ruilope LM; van den Meiracker AH; Ito S; Hasebe N; Webb DJ
    J Hypertens; 2018 Mar; 36(3):451-461. PubMed ID: 29120962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
    Wiemer G; Schölkens BA; Becker RH; Busse R
    Hypertension; 1991 Oct; 18(4):558-63. PubMed ID: 1655653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE2 and the Homolog Collectrin in the Modulation of Nitric Oxide and Oxidative Stress in Blood Pressure Homeostasis and Vascular Injury.
    Yang G; Chu PL; Rump LC; Le TH; Stegbauer J
    Antioxid Redox Signal; 2017 Apr; 26(12):645-659. PubMed ID: 27889958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.